Moderna Inc
Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and […]
Read More
RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters […]
Read More
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead […]
Read More
Stocks making the biggest premarket moves: Cleveland-Cliffs, Nucor, Moderna, Tesla and more
Check out the companies making the biggest moves in premarket trading: Steel stocks — Shares of steel companies soared after President Donald Trump doubled tariffs on the metal to 50% from 25%. Cleveland-Cliffs rallied 26%, while Nucor added nearly 11% and Steel Dynamics rose 10%. BioNTech — The Germany-based biotech stock jumped 11.3% after Bristol […]
Read More
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19 […]
Read More
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight […]
Read More
Stocks making the biggest moves midday: D-Wave Quantum, Moderna, Agilysys, Tesla and more
Check out the companies making headlines in midday trading. D-Wave Quantum — The quantum computing stock surged more than 26% after announcing its latest computing system called Advantage2. Agilysys — The enterprise software developer for the hospitality industry rallied 21% after topping analysts expectations in its latest quarter. Agilysys reported fiscal fourth-quarter adjusted EBITDA of […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Stocks making the biggest moves midday: CoreWeave, Canada Goose, Tesla, United Airlines and more
Check out the companies making headlines in midday trading. CoreWeave — Shares of the cloud provider tumbled more than 9% in its second trading session since going public. CoreWeave, which rents out access to Nvidia graphics processing units to other large tech companies, suffered a disappointing debut last week. Nvidia also saw its shares drop […]
Read More
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about […]
Read More